Digoxin vs Pembrolizumab

Digoxin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Digoxin and Pembrolizumab.

Mechanism of Action

Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Digoxin — 36-48 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Digoxin — C41H64O14.

Molecular Weight: Digoxin — 780.9430 g/mol.

Type: Digoxin — Small molecule; Pembrolizumab — Antibody.